The first interim safety results from a multicenter, safety surveillance study of Alzheimer's disease patients treated with ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease (AD) and other ...
STRONG WILL BE PARTICIPATING IN THE RIDE TO END ALZHEIMER’S IN SOUTH CAROLINA CYCLING MORE THAN 200 MILES TO RAISE MONEY AND AWARENESS FOR ALZHEIMER’S. IN MAY OF 2021. WYFF NEWS FORCE GEOFF HART ...
Friday, April 17, is “End Alz Day”, a day of unity in the fight against Alzheimer’s. “On this day, we stand together to raise ...
NEW YORK, April 2, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative treatments for unmet medical needs, today announced ...
In April, the future was looking bleak for an experimental Alzheimer's drug called valiltramiprosate, or ALZ-801. Researchers had just released topline results of a study of more than 300 people age ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with ...
Please provide your email address to receive an email when new articles are posted on . Alzheon Inc. has enrolled patients who completed either phase 2 or phase 3 trials to evaluate ALZ-801 as a ...
EverythingLubbock.com on MSN
Grab a racket for Do What You Love to End Alzheimer’s
LUBBOCK, Texas—Grab a racket for Do What You Love to End Alzheimer’s. Lubbock Indoor Pickleball is doing what they LOVE to ...
NEWBERRY, S.C. (WCSC) - The July heat isn’t stopping hundreds of cyclists from pedaling from one side of South Carolina to the other over the next three days. Their goal is to support those fighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results